Real-time enrollment status for this cannabinoid hyperemesis syndrome clinical trial
Current Status
Completed
Checked: October 15, 2026 at 2:09 AM UTC
| NCT Number | NCT07246187 |
| Recruiting Status | Completed |
| Condition | Cannabinoid Hyperemesis Syndrome |
| Phase | PHASE3 |
| Target Enrollment | 114 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Mercy Bon Secours Saint Vincent Medical Center |
| Last Updated on CT.gov | October 14, 2026 (Yesterday) |
As of October 15, 2026: Clinical trial NCT07246187 is currently completed participants. This phase3 study for cannabinoid hyperemesis syndrome is not currently accepting new participants at 1 location across the United States. The study is sponsored by Mercy Bon Secours Saint Vincent Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT07246187 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07246187 was last updated Yesterday (October 14, 2026). HelloStudys verifies this status automatically.